Shares with breakthrough potential? Evotec, Varta, and Carbon Done Right Developments

Evotec: News frenzy continues

The new Evotec Management Board is kicking off with a flurry of news. The partnership with Pfizer announced yesterday is the latest success story - we first reported on the cooperation in biosimilars yesterday. The biotech company's share price reacted with a jump of around 4% and is again approaching the resistance level at EUR 10. A multi-year research collaboration, as well as an option and license agreement in the areas of metabolic and infectious diseases, have been agreed with Pfizer. The research work will take place at Evotec's facilities in France. Evotec will receive research payments from Pfizer and be eligible for potential milestone and license payments if the projects succeed.

Pfizer manager Dr. Luca Mollo: "We are excited to collaborate with Evotec to conduct research that can help develop new approaches to treat common metabolic and infectious diseases that affect millions of patients worldwide. France has developed a strong biopharmaceutical ecosystem, and we are delighted to work with Evotec to expand our joint commitment to advancing scientific research into diseases with unmet needs."

Carbon Done Right Developments: Share price fireworks after AIM listing?

Milestone payments are also regularly received by Carbon Done Right Developments Inc. The Company is currently building an exciting platform around climate protection and carbon credits and is establishing itself in a market worth billions. The market capitalization of the Canadian company is presently less than CAD 5 million. Preparations are underway for a listing on the Alternative Investment Market (AIM) of the London Stock Exchange, which should significantly increase awareness of the Company and its shares. The British oil company BP is also a customer.

The core business is the reforestation of large areas and the creation of marine biotopes, for example, in Asia, Africa, and South America. Carbon Done Right Developments then uses artificial intelligence and big data to monitor and document carbon sequestration. The CO2 certificates generated in this way are sold to companies worldwide.

This year, the business model has already been expanded to include a London-based blockchain-supported trading platform for emission certificates. The Company is thus building an entire ecosystem for emissions savings and trading. If the next milestones are reached, the share will likely no longer be as cheap as it currently is.

Varta: Is Porsche becoming a game changer?

It has been a while since we have read such positive news from Varta. At the end of last week, the battery manufacturer announced that it was negotiating the sale of a majority stake in the large-format lithium-ion cell division (V4Drive) with Porsche. A non-binding term sheet had been signed. The V4Drive business is to be bundled in V4Drive Battery GmbH, and Porsche is to participate via a capital increase.

However, this does not change the fact that Varta is still having serious difficulties. The existing IDW-S6 report is still being updated. In addition, Varta is still working on options for potential recapitalization and financing measures.

Therefore, analysts are also hitting the euphoria brake. Following the Porsche report, Warburg confirmed its "Sell" recommendation. Of course, the spin-off of the V4Drive business is fundamentally positive, but it has little impact on Varta's restructuring efforts. Therefore, they see the Varta share as fairly valued at EUR 8.

Even for Berenberg, the collaboration with Porsche would not be a game changer. According to analysts, Varta is currently a "Hold". The target price has been reduced from EUR 22 to EUR 15. The shares of the former German battery hopeful are trading at EUR 10.

Varta is probably still only for real gamblers, as the Company's future is anything but secure. The Carbon Done Right Developments share is anything but expensive. If there is more positive news in the coming months and the share is listed on AIM, it could go up quickly and powerfully. At Evotec, the latest newsflow is encouraging. If the momentum continues, investors should soon forget the problems of the first half of the year.